What is Wedbush’s Estimate for RCUS FY2029 Earnings?
Arcus Biosciences, Inc. (NYSE:RCUS – Free Report) – Research analysts at Wedbush issued their FY2029 EPS estimates for shares of Arcus Biosciences in a note issued to investors on Tuesday, February 18th. Wedbush analyst R. Driscoll anticipates that the company will post earnings per share of $3.03 for the year. Wedbush currently has a “Outperform” […]
